Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination [Yahoo! Finance]
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™ [Yahoo! Finance]
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™ [Financial Post (Toronto, Ontario, Canada)]
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™